...
首页> 外文期刊>Journal of clinical lipidology >An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report
【24h】

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia - Full report

机译:国际动脉粥样硬化学会立场文件:血脂异常管理的全球建议-全文报告

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An international panel of the International Atherosclerosis Society has developed a new set of recommendations for the management of dyslipidemia. The panel identifies non - high-density lipoprotein cholesterol as the major atherogenic lipoprotein. Primary and secondary prevention are considered separately. Optimal levels for atherogenic lipoproteins are derived for the two forms of prevention. For primary prevention, the recommendations emphasize lifestyle therapies to reduce atherogenic lipoproteins; drug therapy is reserved for subjects at greater risk. Risk assessment is based on estimation of lifetime risk according to differences in baseline population risk in different nations or regions. Secondary prevention emphasizes use of cholesterol-lowering drugs to attain optimal levels of atherogenic lipoproteins.
机译:国际动脉粥样硬化学会的一个国际小组已经制定了一套新的血脂异常管理建议。该小组确定非高密度脂蛋白胆固醇是主要的动脉粥样硬化脂蛋白。一级和二级预防分开考虑。两种形式的预防方法得出了致动脉粥样硬化脂蛋白的最佳水平。对于一级预防,建议强调生活方式疗法以减少动脉粥样硬化脂蛋白。药物治疗是专为高危人群准备的。风险评估是根据不同国家或地区基线人口风险的差异来估计生命风险。二级预防强调使用降低胆固醇的药物,以达到最佳水平的动脉粥样硬化脂蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号